The Program in Quantitative Genomics at the Harvard School of Public Health, jointly with the HSPH Department of Biostatistics and the Department of Biostatistics and Computational Biology at the Dana-Farber Cancer Institute, will host its 7th two-day conference on November 14-15, 2013 at the Joseph B. Martin Conference at Harvard Medical School in Boston, MA.

The conference will be entitled “Emerging Quantitative Issues in Disease Epigenetics” and will seek to examine the interplay between emerging technologies, its applications to diseases epigenetics studies, and interdisciplinary challenges of data analysis involved. We seek to engage scientists working in experimental, clinical, and computational epigenomics in a discussion centered on three important topics:


  1. Chromatin regulation in diseases
  2. Epigenetics of genetic variance in disease
  3. DNA methylation, somatic mutations, and diseases


The conference schedule includes time for scientific presentations, as well as a poster session for submitted abstracts.

Three abstracts will be selected for Stellar Abstract Awards and to be presented as 15-minute platform talks. Each of these speakers will receive an award of up to $500 for travel assistance or other conference expenses.


2013 PQG Conference Donors:

pqg           HSPH          DFCI

NCI          nhgri_logo      PSOC

blank1 Diagenode1           epizyme


Funding for this conference was made possible (in part) by a Grant from the National Cancer Institute. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices or organizations imply endorsement by the U.S. Government.